These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2908331)

  • 1. Pharmacologic management of behavioral problems in adult dental patients with severe cognitive impairment.
    Volicer L
    Gerodontics; 1988 Aug; 4(4):160-1. PubMed ID: 2908331
    [No Abstract]   [Full Text] [Related]  

  • 2. Cognitive failure in end of life.
    Ostgathe C; Gaertner J; Voltz R
    Curr Opin Support Palliat Care; 2008 Sep; 2(3):187-91. PubMed ID: 18685419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranquilizers, stimulants, and enhancers of cognition.
    Flitman SS
    Phys Med Rehabil Clin N Am; 1999 May; 10(2):463-72, ix. PubMed ID: 10370941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug treatment of anxiety and agitation in the aged.
    Petrie WM
    Psychopharmacol Bull; 1983; 19(2):238-46. PubMed ID: 6135237
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-related methods for alleviation of stress in dentistry.
    Tolksdorf W; Siefert S
    Anesth Pain Control Dent; 1992; 1(1):34-41. PubMed ID: 1356540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic treatment of pediatric insomnia.
    Owens JA; Moturi S
    Child Adolesc Psychiatr Clin N Am; 2009 Oct; 18(4):1001-16. PubMed ID: 19836701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive effects of atypical antipsychotics in patients with Alzheimer's disease and comorbid psychiatric or behavioral problems: a retrospective study.
    Caballero J; Hitchcock M; Scharre D; Beversdorf D; Nahata MC
    Clin Ther; 2006 Oct; 28(10):1695-700. PubMed ID: 17157125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drugs for bipolar disorder.
    Sanches M; Soares JC
    Curr Psychiatry Rep; 2011 Dec; 13(6):513-21. PubMed ID: 21877160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the use of protective stabilization in dental patients with cognitive disabilities.
    Karibe H; Umezu Y; Hasegawa Y; Ogihara E; Masuda R; Ogata K; Shirase T; Kawakami T; Warita S
    Spec Care Dentist; 2008; 28(5):214-20. PubMed ID: 18782199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antipsychotic drug therapy for patients with behavioral and psychological symptoms of dementia(BPSD)].
    Kudo T
    Seishin Shinkeigaku Zasshi; 2007; 109(7):657-63. PubMed ID: 17969953
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of the behavioral manifestations of dementia.
    Yeager BF; Farnett LE; Ruzicka SA
    Arch Intern Med; 1995 Feb; 155(3):250-60. PubMed ID: 7832596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with antipsychotic drug use in residential care: changes between 1990 and 1997.
    Lindesay J; Matthews R; Jagger C
    Int J Geriatr Psychiatry; 2003 Jun; 18(6):511-9. PubMed ID: 12789672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dental treatment planning for patients with severe cognitive impairment.
    Gordon SR
    Gerodontics; 1988 Aug; 4(4):162-4. PubMed ID: 2978568
    [No Abstract]   [Full Text] [Related]  

  • 14. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.
    Mishara AL; Goldberg TE
    Biol Psychiatry; 2004 May; 55(10):1013-22. PubMed ID: 15121486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of anxiety states: some theoretical and practical aspects.
    Dennis JL; Hendrie HC
    J Indiana State Med Assoc; 1980 May; 73(5):300-5. PubMed ID: 6107320
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurocognitive costs and benefits of psychotropic medications in older adults.
    Brooks JO; Hoblyn JC
    J Geriatr Psychiatry Neurol; 2007 Dec; 20(4):199-214. PubMed ID: 18004007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypnotics and tranquillisers for elderly patients.
    Cooper P
    Midwife Health Visit; 1972 Nov; 8(11):397. PubMed ID: 4489500
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2007 Feb; 5(54):9-14. PubMed ID: 17261969
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of post partum schizophrenia-like episodes in ambulatory states].
    Măgureanu M; Trifan A; Cozma S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(3):235-8. PubMed ID: 6132441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.